The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.

Objectives: To investigate the outcome of patients with acute myocardial infarction (AMI) complicated by refractory cardiogenic shock (CS) who underwent mechanical circulatory support with Impella 2.5.

Background: AMI complicated by CS remains a highly fatal condition.